Regeneron Completes Acquiring Sanofi's Stake In Libtayo

RTTNews | 658 days ago
Stocktwits
Regeneron Completes Acquiring Sanofi's Stake In Libtayo

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.

With today's closing, Regeneron will now record 100% of global net sales and expenses for Libtayo.

Regeneron intends to update its full year 2022 financial guidance to reflect the Libtayo purchase during its second quarter 2022 earnings announcement in early August.

On May 31, 2022, Regeneron announced that it had successfully acquired Checkmate Pharmaceuticals, Inc. for a total equity value of approximately $250 million.

As a result of the Checkmate acquisition, Regeneron expects to record in the second quarter of 2022 an acquired in-process research and development (IPR&D) charge of approximately $195 million, which would negatively impact GAAP and non-GAAP diluted earnings per share by approximately $1.70.

Tags: SNY REGN SNYNF
Stocktwits
read more
Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharmaceuticals, Inc. (REGN) reported on Friday that net income for the fourth quarter declined 3 percent to $1.16 billion or $10.19 per share from $1.20 billion or $10.50 per share in the prior-year quarter.
RTTNews | 77 days ago
Sanofi Q3 Profit Rises, Backs FY23 View, To Split Consumer Healthcare Unit; Stock Dips

Sanofi Q3 Profit Rises, Backs FY23 View, To Split Consumer Healthcare Unit; Stock Dips

French drug major Sanofi reported Friday higher profit in its third quarter, while sales declined. Further, the company reiterated fiscal 2023 business earnings view. Separately, Sanofi said it plans to separate the Consumer Healthcare Business with a view to focus on Biopharma business. Sanofi shares were losing more than 15 percent in the morning trading in Paris.
RTTNews | 175 days ago
Sanofi Q4 Profit Climbs, Sees Slower Earnings Growth In FY23; Stock Down

Sanofi Q4 Profit Climbs, Sees Slower Earnings Growth In FY23; Stock Down

French drug major Sanofi SA reported Friday higher profit in its fourth quarter with strong revenue growth mainly with strong sales of Dupixent. Looking ahead for fiscal 2023, the company projects higher business earnings, but the expected growth is slower than recorded in fiscal 2022. Sanofi shares were losing around 4 percent in the morning trading in Paris as well as in pre-market activity...
RTTNews | 441 days ago
Paramount Stock Up In Pre-market On Reports Of Sony-Apollo Joint Bid Talks

Paramount Stock Up In Pre-market On Reports Of Sony-Apollo Joint Bid Talks

Sony Pictures Entertainment, affiliated to Japanese conglomerate Sony Group Corp., is in discussions with US private equity group Apollo Global for making a joint takeover bid for entertainment giant Paramount Global, reports said citing people familiar with the matter. The talks are said to be in an early stage. Following the news, Paramount Global shares were gaining around 10.7 percent...
RTTNews | 4h 18min ago
FTSE 100 Slides As Retail Sales Stall In March

FTSE 100 Slides As Retail Sales Stall In March

U.K. stocks declined on Friday as Middle East tensions flared up and investors scaled back their expectations for the Federal Reserve to cut interest rates this year.
RTTNews | 4h 19min ago
CAC 40 Drifts Lower On Rate Worries, Mideast Tensions

CAC 40 Drifts Lower On Rate Worries, Mideast Tensions

French stocks edged lower on Friday as an escalation of the tensions in the Middle East and cautious comments from more Federal Reserve officials on how to manage inflation and interest rates in the coming months soured investor mood.
RTTNews | 4h 29min ago
UK Retail Sales Stable In March

UK Retail Sales Stable In March

UK retail sales were unchanged on a month-on-month basis in March, defying expectations for a gain, preliminary data from the Office for National Statistics showed Friday. Retail sales including automotive fuel grew 0.1 percent in the previous month. Economists were looking for a 0.3 percent gain for March.
RTTNews | 4h 32min ago
Tools
Economic Calendar
Market Hours
Interest Rates
Holidays Calendar
Forex Market
Forex Volatility
Forex Correlation
Forex News
forex analysis
COT Data
Liquidity
Forex Calculators
Forex Heat Map
Indicators Heatmap
Community
Community
Systems
Most Popular Systems
Strategies
Contests
Forex Charts
Forex Sentiment
Outlook Indicator
Reviews
Brokers
Crypto Exchanges
Expert Advisors
Signal Providers
VPS Services
EA Programming
PAMM Brokers
Rebate Programs
Trading Platforms
Prop Trading Firms
Brokers
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Broker News
Platform
Widgets
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2024 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.